Clinical trial
Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen and Smart B in Women With Climacteric Syndrome in Perimenopause
NCT03897738 is registered in ClinicalTrials.gov with I.M. Sechenov First Moscow State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of Effectiveness and Safety of Combined Use of Dietary Supplements Amberen and Smart B in Women With Climacteric Syndrome in Perimenopause
- Lead sponsor
- I.M. Sechenov First Moscow State Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2019
- Completion date
- February 18, 2020
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
perimenopause, climacteric syndrome